Researchers at UT Southwestern Medical Center discovered that genetically modifying fat cells in obese mice to produce higher ...

According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...

Not long after Librela's FDA approval, Facebook and other social media groups began forming about serious side effects.